Product
Group N; Neostigmine + Atropine
1 clinical trial
3 indications
Indication
Postoperative VomitingIndication
postoperative nauseaIndication
Postoperative DeliriumClinical trial
Comparison of Sugammadex and Neostigmine in Terms of Awakening, Pain, Agitation, Nausea and Vomiting in Pediatric Patients''Status: Completed, Estimated PCD: 2023-10-25